Brief: Tetra Bio-Pharma And Altus Formulation Sign JV Agreement For Cannabinoid Drug Product Development
29/04/2019 11:53
April 29 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA AND ALTUS FORMULATION SIGN JOINT VENTURE
AGREEMENT FOR CANNABINOID DRUG PRODUCT DEVELOPMENT
* TETRA BIO PHARMA INC - SIGNING OF A JOINT VENTURE
AGREEMENT
UNDER WHICH TWO COMPANIES WILL WORK TOGETHER TO DEVELOP A SERIES
OF CANNABINOID-RECEPTOR
Source text for Eikon: ID:nGNX7bvmNM
Further company coverage: TBP.V
(Reuters.Briefs@thomsonreuters.com)
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding